Drug intelligence / Profile preview

methylcobalamin

Development stage
Unknown
Lead developer
Biomed
Modality
Small Molecules
Administration
Oral
01

Overview

B12 Max Metylo is a dietary supplement or food for special medical purposes (FSMP) containing a high dose of methylcobalamin, the biologically active coenzyme form of vitamin B12. Developed and marketed by IBSS Biomed, it is used to manage vitamin B12 deficiency and support the proper functioning of the nervous and immune systems, as well as to maintain normal homocysteine metabolism and red blood cell production. Methylcobalamin serves as a critical cofactor for the enzyme methionine synthase, which facilitates the remethylation of homocysteine to the essential amino acid methionine. This biochemical pathway is vital for DNA synthesis, methylation processes, and the maintenance of the myelin sheath surrounding nerve fibers. Unlike cyanocobalamin, methylcobalamin does not require metabolic conversion to be utilized by the body.

Brand names
B12 Max MetyloB-12 Max MetyloB 12 Max Metylo
Other names
mecobalaminmethyl B12methylcobalaminum
02

Targets

MTR (Methionine synthase)

Beyond the preview

Go deeper on methylcobalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylcobalamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call